When to Order Imaging for Chronic Chest Pain-High Probability of Coronary Artery Disease: ACR Appropriateness Decoded

When to Order Imaging for Chronic Chest Pain-High Probability of Coronary Artery Disease: ACR Appropriateness Decoded

A 68-year-old with diabetes and hypertension presents to your clinic with stable, exertional chest pressure. The story is classic, and your pre-test probability for coronary artery disease (CAD) is high. Do you start with a functional stress test, go straight to an anatomic study like a coronary CTA, or consider invasive angiography? Making the right initial imaging choice is critical for efficient diagnosis and management. The American College of Radiology (ACR) provides evidence-based guidance to navigate this common and critical decision point, helping clinicians select the most appropriate study based on the specific clinical context.

This article decodes the ACR Appropriateness Criteria for chronic chest pain in patients with a high pre-test probability of CAD, providing a scannable reference for ordering physicians, residents, and fellows. We will review the key clinical scenarios, outline the recommended imaging modalities, and provide a quick-reference table to support your clinical decision-making.

What Does ACR Chronic Chest Pain-High Probability of Coronary Artery Disease Cover?

The ACR Appropriateness Criteria for “Chronic Chest Pain-High Probability of Coronary Artery Disease” focuses on patients presenting with stable, chronic chest pain where clinical assessment suggests a significant likelihood of underlying obstructive CAD. This guidance is intended for the initial diagnostic workup in this specific population.

This topic specifically applies to two primary patient groups:

• Patients with a high pre-test probability of CAD but no previously diagnosed ischemic heart disease.
• Patients with known ischemic heart disease who have not yet undergone definitive treatment (like stenting or bypass surgery) and are presenting with new or worsening chronic symptoms.

It is important to note what this guideline does not cover. It is not intended for patients with acute chest pain, where the primary concern is acute coronary syndrome (ACS). It also does not apply to patients with a low or intermediate pre-test probability of CAD, for whom the diagnostic algorithm and imaging recommendations differ significantly. Finally, this guidance is for initial imaging and does not cover subsequent surveillance or post-revascularization imaging scenarios.

What Imaging Should I Order for Chronic Chest Pain-High Probability of Coronary Artery Disease? Recommendations by Clinical Scenario

The ACR panel provides detailed recommendations based on the patient’s known cardiac history. The choice between functional and anatomic testing often depends on local expertise, patient-specific factors (such as renal function or ability to exercise), and the clinical question being asked.

For a patient with chronic chest pain, a high probability of coronary artery disease, and no known ischemic heart disease, the ACR provides a broad range of options rated as “Usually Appropriate.” This reflects the fact that multiple modalities can effectively evaluate for significant stenosis. These include functional tests like Transthoracic Stress Echocardiography, Stress Cardiac MRI (with or without contrast), and nuclear imaging (Rb-82 PET/CT or SPECT MPI). Anatomic tests are also highly rated, including Coronary CTA with IV contrast and invasive Coronary Arteriography. The choice often hinges on whether the primary goal is to assess ischemia (functional) or define anatomy (anatomic). Studies like a resting echocardiogram or a coronary calcium score are rated “May be appropriate,” as they provide useful information but are less definitive for diagnosing flow-limiting disease in this high-risk population.

For a patient with chronic chest pain, a high probability of CAD, and known ischemic heart disease with no prior definitive treatment, the recommendations are similar. The same functional and anatomic studies—Stress Echocardiography, Stress Cardiac MRI, Coronary CTA, Nuclear PET/SPECT, and Coronary Arteriography—are all rated “Usually Appropriate.” In this context, imaging helps determine the extent and severity of ischemia to guide decisions about revascularization. A key difference is that a CT coronary calcium score is now “Usually Not Appropriate,” as the presence of CAD is already established, and the calcium score adds little new information for management. A resting transthoracic echocardiogram is rated “May be appropriate (Disagreement),” indicating variability in expert opinion on its utility as a first-line test in this scenario.

ACR Imaging Recommendations Table

Adult vs. Pediatric Chronic Chest Pain-High Probability of Coronary Artery Disease Imaging: Radiation Dose Tradeoffs

Chronic chest pain secondary to coronary artery disease is exceedingly rare in the pediatric population. However, the ACR provides pediatric relative radiation level (RRL) estimates for certain studies to guide imaging in rare cases, such as in children with Kawasaki disease, familial hypercholesterolemia, or post-heart transplant vasculopathy. The fundamental principle of As Low As Reasonably Achievable (ALARA) is paramount in pediatric imaging due to the increased lifetime risk of radiation-induced malignancy.

For this reason, non-ionizing modalities like Stress Echocardiography and Stress Cardiac MRI (both with a radiation level of O) are strongly preferred when clinically appropriate. When ionizing radiation is necessary, such as with Coronary CTA or SPECT MPI, protocols must be aggressively optimized for pediatric patients to minimize dose. The pediatric RRL for these studies is often in a higher category (e.g., ☢ ☢ ☢ ☢ or ☢ ☢ ☢ ☢ ☢) than the adult equivalent, reflecting the complexity and potential for higher relative doses if protocols are not carefully tailored to the child’s size and weight.

Tools to Help You Order the Right Study

Navigating imaging guidelines can be complex, but several tools can streamline the process of selecting the right study and understanding its implications. These resources are designed to bring evidence-based standards directly into the clinical workflow.

For scenarios beyond chronic chest pain, the ACR Appropriateness Criteria Lookup provides a comprehensive, searchable interface to find official ACR recommendations for thousands of clinical variants. Once a study is chosen, the Imaging Protocol Library offers detailed, step-by-step protocols for performing various exams, ensuring technical consistency and quality. To help discuss radiation exposure with patients and track cumulative dose, the Radiation Dose Calculator is a valuable tool for translating effective dose into understandable terms.

Frequently Asked Questions

What is the main difference between choosing a Coronary CTA versus an invasive coronary arteriography in this high-probability setting?

Coronary CTA is a non-invasive anatomic test that is excellent at ruling out significant stenosis (high negative predictive value). Invasive coronary arteriography (cardiac catheterization) is the gold standard for defining coronary anatomy and has the unique advantage of allowing for immediate percutaneous coronary intervention (PCI) with stenting if a critical lesion is found. In a high-probability patient, the choice often depends on the likelihood of needing intervention and patient preference. If revascularization is highly probable, proceeding directly to invasive angiography can be more efficient.

Why is a coronary calcium score only ‘May be appropriate’ for patients without known CAD and ‘Usually not appropriate’ for those with known CAD?

A coronary artery calcium (CAC) score quantifies the amount of calcified plaque in the coronary arteries. In a patient with no known CAD, it can help reclassify risk. However, in a patient with a high pre-test probability of CAD, the presence of calcium is already assumed, and the score does not provide information about whether a plaque is causing a flow-limiting stenosis. For a patient with already known CAD, the CAC score is redundant and provides no additional value for clinical management, making it “Usually Not Appropriate.”

When should I choose a functional study (stress echo, MRI, nuclear) over an anatomic study (CTA, cath)?

The choice depends on the clinical question. If the primary question is “Does this patient have ischemia?” or “Is their known plaque causing a blood flow problem?”, a functional study is ideal. It directly assesses the physiologic consequence of a potential stenosis. If the question is “What is the coronary anatomy?” or “Is there a high-grade stenosis that may need a stent?”, an anatomic study is more direct. In many high-probability patients, guidelines support either approach as a reasonable first step.

What defines a “high probability” of coronary artery disease in this context?

“High probability” refers to the pre-test probability (PTP) of having obstructive CAD, which is estimated using clinical factors like age, sex, and the nature of the chest pain (typical angina, atypical angina, non-anginal). While specific thresholds vary, a high PTP generally implies a >15% likelihood of obstructive disease based on validated risk models. This clinical assessment is the crucial first step before applying these imaging criteria.

Why is a resting transthoracic echocardiogram (TTE) rated lower than a stress TTE for this indication?

A resting TTE can assess for structural heart disease, global and regional left ventricular function, and valvular abnormalities. It may show a regional wall motion abnormality, suggesting a prior myocardial infarction. However, in a patient with stable angina, the heart muscle function is often normal at rest. A stress TTE is required to provoke ischemia and reveal wall motion abnormalities that only appear under stress, making it a much more sensitive test for detecting flow-limiting coronary artery disease.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 12, 2026